Results 91 to 100 of about 362,020 (233)

Cervical intraepithelial neoplasia in young women

Journal of Obstetrics and Gynaecology, 2007
The aim of the study was to determine the incidence and outcome of cervical intraepithelial neoplasia (CIN) in Greek young women. A retrospective analysis was conducted of women aged 16 - 20 years with a histological diagnosis of CIN during the years 1999-2005. Management was individualised for each case.
Haidopoulos, D., Voulgaris, Z., Protopapas, A., Rodolakis, A., Vlachos, G., Tsetsa, P., Antsaklis, A.   +6 more
openaire   +3 more sources

Human papillomavirus persistence and clearance in women living with HIV: A five‐year retrospective analysis from an Italian university center

Acta Obstetricia et Gynecologica Scandinavica, Volume 105, Issue 10, Page 2041-2047, October 2026.
In women living with HIV, HPV clearance occurred after a mean of approximately 2 years under antiretroviral therapy. Baseline positivity for the high‐risk HPV pool was associated with delayed clearance, suggesting that HPV genotype may influence viral persistence more than immunovirological status in clinically stable patients.
Annunziata Carlea, Dario Colacurci, Giorgia D'Apice, Laura Letizia Mazzarelli, Massimiliano Pellicano, Luigi Falco, Ginevra Sepe, Oriana Imperatore, Giuseppe Maria Maruotti, Maurizio Guida, Laura Sarno   +10 more
wiley   +1 more source

Loss to follow‐up in patients diagnosed with or treated for low‐ and high‐grade squamous intraepithelial lesions: A comparison of general practitioner‐ and gynecologist‐led surveillance

Acta Obstetricia et Gynecologica Scandinavica, Volume 105, Issue 10, Page 2081-2088, October 2026.
Follow‐up by general practitioners after LSIL or treated HSIL was associated with higher loss to follow‐up rates compared with gynecologist‐led care. Loss to follow‐up was 38.1% versus 16.6% for LSIL at 12 months and 44.3% versus 24.1% for treated HSIL at 24 months.
Lieke van de Kam, Albert Siebers, Ruud Bekkers, Dennis van Hamont, Jurgen Piek   +4 more
wiley   +1 more source

Economic modelling assessment of cervical cancer screening and HPV vaccination in Brazil [PDF]

More than 85% of the global burden of cervical cancer occurs in developing countries, where it is the second most common cancer among women. In Brazil alone, a total of 17,500 new cases and 3,300 deaths of cervical cancer are expected in 2012.
Vanni, Tazio
core   +1 more source

New options for early diagnosis and prevention of HPV-associated cervical lesions

Медицинский совет, 2015
The review examines the relationship of human papillomavirus and its role in cervical intraepithelial neoplasia (CIN) and cervical cancer. The most informative methods of diagnostics (immunohistochemical, molecular-genetic and other) and treatment of HPV-
V. N. Prilepskaya, G. R. Bayramova, E. A. Kogan, V. F. Chernova, A. N. Okushko   +4 more
doaj   +1 more source

World Health Organization Guidelines for treatment of cervical intraepithelial neoplasia 2-3 and screen-and-treat strategies to prevent cervical cancer.

, 2016
<p><b>BACKGROUND: </b>It is estimated that 1%-2% of women develop cervical intraepithelial neoplasia grade 2-3 (CIN 2-3) annually worldwide. The prevalence among women living with HIV is higher, at 10%.
E.R. Lu, M.A. Reem, S.E. Forhan, N. Broutet, H.J. Schünemann, N. Santesso, J.C. Gage, Guideline Support Group, R. Herrero, R. Sankaranarayanan, S. Luciani, J. Cain, J. Jeronimo, S.Chong Quek, M. Chirenje, H. De Vuyst, F. Garcia, P.D. Blumenthal, E.L. Franco, V. Tsu, M. Arbyn, L. Denny, L.O.\u27Neal Eckert   +22 more
core   +1 more source

Management for persistent HPV infection and cervical lesions among women infected with HIV: a retrospective observational cohort study

Virology Journal
Background Early diagnosis and treatment of HPV persistent infection and cervical intraepithelial neoplasia, which have yet to be thoroughly characterized in Guangxi, Southwestern China, are the key preventative measures for the development of cervical ...
Dewu Bi, Shuzhen Wei, Xiaolu Luo, Xiaocheng Luo, Xike Tang   +4 more
doaj   +1 more source

Women's experiences, responses, and coping strategies when testing positive for human papillomavirus in cervical cancer screening: A qualitative study

Acta Obstetricia et Gynecologica Scandinavica, Volume 105, Issue 10, Page 2104-2113, October 2026.
This study demonstrates that women's experiences following an hrHPV diagnosis within cervical screening extend beyond individual reactions to medical information, encompassing complex psychological, social, and cultural dimensions that influence how women interpret and manage the diagnosis.
Joan Hansen, Beth J. Maclin, Birgitte Folmann, Jane Ege Møller, Ane Kersti Skaarup Knudsen, Vibeke Raaby, Anne Hammer   +6 more
wiley   +1 more source

Non-detection of human herpesvirus 8 (HHV-8) DNA in HHV-8-seropositive blood donors from three Brazilian regions. [PDF]

, 2011
Human herpesvirus 8 (HHV-8), also known as Kaposi's sarcoma-associated herpesvirus (KSHV), is the etiologic agent of all forms of Kaposi's sarcoma, primary effusion lymphoma and the plasmablastic cell variant of multicentric Castleman disease. In endemic
de Souza Vanda Akico Ueda Fick, Sumita Laura Masami, Nascimento, Maria Claudia do, FREIRE, Wilton S., Nascimento, Maria Claudia, SOUZA, Vanda Akico Ueda Fick de, Claudio S Pannuti, Mayaud Philippe, Pannuti Claudio S., Vanda Akico Ueda Fick de Souza, Wilton S. Freire, Wilton S Freire, Freire Wilton S., PANNUTI, Claudio S., Levi, José Eduardo, Maria Claudia Nascimento, de Souza, Vanda Akico Ueda Fick, Nascimento Maria Claudia, Pannuti, Claudio S, Mayaud, Philippe, Freire, Wilton S, Levi José Eduardo, Laura Masami Sumita, Philippe Mayaud, Claudio S. Pannuti, Sumita, Laura Masami, José Eduardo Levi   +26 more
core   +2 more sources

Health Care Policy Implementation Trial of Primary Human Papillomavirus–Based Cervical Screening in Denmark

International Journal of Cancer, Volume 159, Issue 6, Page 1464-1476, 15 September 2026.
Uncertainty has persisted over whether human papillomavirus (HPV) testing outperforms high‐quality cytology in real‐world cervical cancer screening programs. To address this, Denmark launched a nationwide trial in 2021, implementing an HPV‐based screening strategy using specialized algorithms integrated with molecular and cytology triage to optimize ...
Jesper Bonde, Jeppe Bennekou Schroll, Birgitte Tønnes Pedersen, Elsebeth Lynge, Marianne Waldstrøm, Petra Hall Viborg, Anna Frandsen, Rikke Holst Andersen, Susanne Nielsen, Doris Schledermann, Bettina Kjær Kristensen, Berit Andersen, on behalf of the National Danish Cervical Cancer Screening Steering Committee   +12 more
wiley   +1 more source